Shahid Ahmad

Today we introduce Elicit Alerts, a new way to stay informed about relevant research with AI. * Governments and philanthropists need to be aware of new evidence for or against social programs * Pharmaceutical companies need to learn about promising molecules and biological targets as they emerge * CPG companies need to know

“Elicit can extract technically complex variables from an enormous volume of papers with researcher-level accuracy – that’s incredible.” – Sandeep Basnet, MD, Senior Director of Clinical Development, Formation Bio Formation Bio is a New York-based AI-native pharmaceutical company combining sophisticated drug development strategy with AI technology to power hyper-efficient drug development.

“Using Elicit, we recently conducted a ‘rapid literature review’ investigating 40 research questions across almost 500 papers. In the past, we would never have been able to conduct a rapid literature review of that scale. This technology allows us to offer clients deeper insights across larger evidence bases than ever

Today we're excited to introduce Elicit Reports: fully-automated research overviews for actual researchers, inspired by systematic reviews. Elicit Reports rigorously summarize research by building on the systematic review process, the gold standard for synthesizing scientific literature. They conduct a fully-automated rapid review (search, screening, data extraction) using the

With Elicit, we can produce a very high quality review for clients in a couple of months. That’s a valuable selling point.” Veit Wasserfuhr, Consultant, VDI/VDE-IT VDI/VDE Innovation + Technik GmbH is a German consulting firm that advises governments and the private sector on innovation and technology. In

“Elicit is a step above other tools I've tried. I prefer Elicit when it comes to actually interpreting evidence. It doesn't make things up like ChatGPT.” - James Compagno, Director of Marketing MicroGenDX is a clinical laboratory that offers microbial diagnostic tests via next-generation DNA sequencing